Back
Novartis AG 10K Form
Buy
67
NVS
Novartis AG
Last Price:
100.75
Seasonality Move:
1.26%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVS News And Ratings
See the #1 stock for the next 7 days that we like better than NVS
NVS Financial Statistics
Sales & Book Value
| Annual Sales: | $51.83B |
|---|---|
| Cash Flow: | $2.58B |
| Price / Cash Flow: | 17 |
| Annual Sales: | $25.07 |
| Price / Book: | 4.02 |
Profitability
| EPS (TTM): | 3.59000 |
|---|---|
| Net Income (TTM): | $7.65B |
| Gross Margin: | $36.34B |
| Return on Equity: | 13.32% |
| Return on Assets: | 6.57% |
Novartis AG Earnings Forecast
Key Novartis AG Financial Ratios
- The Gross Profit Margin over the past 25 years for NVS is 70.12%.
- The Selling, General & Administrative Expenses for NVS have been equal to 27.50% of Gross Profit Margin.
- The Research & Development expenses have been 19.29% of Revenue.
- The Interest Expense is 12.03% of Operating Income.
- The Net Earning history of NVS is 13.42% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 16 years.
Novartis AG Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Drug Manufacturers - General |
| Sector: | Healthcare |
| Current Symbol: | NVS |
| CUSIP: | 66987V |
| Website: | novartis.com |
Debt
| Debt-to-Equity Ratio: | 0.51 |
|---|---|
| Current Ratio: | 1.05 |
| Quick Ratio: | 0.65 |
Price-to-Earnings
| Trailing P/E Ratio: | 31.77 |
|---|---|
| Forward P/E Ratio: | 13.72 |
NVS Technical Analysis vs Fundamental Analysis
Buy
67
Novartis AG (NVS)
is a Buy
Is Novartis AG a Buy or a Sell?
-
Novartis AG stock is rated a Buy
The current Novartis AG [NVS] share price is $100.72. The Score for NVS is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.